CN120981170A - 神经炎症改善用组合物、脑功能改善用组合物、脂质代谢改善用组合物、肠道菌群构成比率调整用组合物及植物炭的用途 - Google Patents

神经炎症改善用组合物、脑功能改善用组合物、脂质代谢改善用组合物、肠道菌群构成比率调整用组合物及植物炭的用途

Info

Publication number
CN120981170A
CN120981170A CN202480026910.9A CN202480026910A CN120981170A CN 120981170 A CN120981170 A CN 120981170A CN 202480026910 A CN202480026910 A CN 202480026910A CN 120981170 A CN120981170 A CN 120981170A
Authority
CN
China
Prior art keywords
composition
charcoal
compositions
improving
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480026910.9A
Other languages
English (en)
Chinese (zh)
Inventor
金谷智之
藤野武彦
马渡志郎
庭濑纱明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Third International Co ltd
Original Assignee
Third International Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Third International Co ltd filed Critical Third International Co ltd
Publication of CN120981170A publication Critical patent/CN120981170A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
CN202480026910.9A 2023-04-20 2024-04-19 神经炎症改善用组合物、脑功能改善用组合物、脂质代谢改善用组合物、肠道菌群构成比率调整用组合物及植物炭的用途 Pending CN120981170A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-069368 2023-04-20
JP2023069368 2023-04-20
PCT/JP2024/015562 WO2024219487A1 (ja) 2023-04-20 2024-04-19 神経炎症改善用組成物、脳機能改善用組成物、脂質代謝改善用組成物、腸内細菌叢構成比率調整用組成物及び植物炭の使用

Publications (1)

Publication Number Publication Date
CN120981170A true CN120981170A (zh) 2025-11-18

Family

ID=93152936

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480026910.9A Pending CN120981170A (zh) 2023-04-20 2024-04-19 神经炎症改善用组合物、脑功能改善用组合物、脂质代谢改善用组合物、肠道菌群构成比率调整用组合物及植物炭的用途

Country Status (4)

Country Link
JP (1) JPWO2024219487A1 (https=)
CN (1) CN120981170A (https=)
TW (1) TW202506164A (https=)
WO (1) WO2024219487A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3338119B2 (ja) * 1993-04-14 2002-10-28 呉羽化学工業株式会社 抗糖尿病剤
JP7573842B2 (ja) * 2018-06-07 2024-10-28 株式会社ラテスト 機能性食品
CN113875984B (zh) * 2020-07-02 2024-04-19 成都一平医药科技发展有限公司 一种用于控制体重的组合物
CN118811793A (zh) * 2022-07-19 2024-10-22 浙江长三角聚农科技开发有限公司 一种竹笋生物炭及其制备方法与应用

Also Published As

Publication number Publication date
JPWO2024219487A1 (https=) 2024-10-24
WO2024219487A1 (ja) 2024-10-24
TW202506164A (zh) 2025-02-16

Similar Documents

Publication Publication Date Title
Cao et al. The protective effects of yellow tea extract against loperamide-induced constipation in mice
Lindsay et al. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis
Wan et al. Dicaffeoylquinic acids from Ilex kudingcha attenuate dextran sulfate sodium-induced colitis in C57BL/6 mice in association with the modulation of gut microbiota
Dong et al. Ethyl pyruvate protects against Salmonella intestinal infection in mice through down-regulation of pro-inflammatory factors and inhibition of TLR4/MAPK pathway
CN106999515B (zh) 含有亚铁胺基酸螯合物的组合物在制备调控脂肪代谢的药物的用途
WO2019235099A1 (ja) 機能性食品
Luo et al. Astaxanthin nanoparticles ameliorate dextran sulfate sodium-induced colitis by alleviating oxidative stress, regulating intestinal flora, and protecting the intestinal barrier
JP2011522844A (ja) 血糖レベルを低下させる組成物及びその用途
CN107349190B (zh) 芳姜黄酮的应用
Jaafar et al. Constipation anti-aging effects by dairy-based lactic acid bacteria
CN120981170A (zh) 神经炎症改善用组合物、脑功能改善用组合物、脂质代谢改善用组合物、肠道菌群构成比率调整用组合物及植物炭的用途
CN106474132B (zh) 聚普瑞锌在制备治疗或减轻放化疗所致消化道并发症及肠易激综合征药物中的应用
CN117045686B (zh) 解纤维素拟杆菌在制备药物中的应用
CN116531410B (zh) 白色葡萄球菌在制备组合物中的应用
TWI818267B (zh) 小分子克弗爾胞外多醣萃取物用於治療或預防糖尿病及促進胰島再生與抗發炎之用途
WO2016052509A1 (ja) 腎不全進行抑制剤、腎不全予防剤及びインドキシル硫酸産生阻害剤
CN118542859A (zh) 异荭草苷在治疗炎症性肠病中的用途
WO2005074961A1 (ja) 体脂肪調整剤
CN113368182A (zh) 一种预防或治疗糖尿病脑病的中药组合物及其用途
EP4267114A1 (en) Zein nanoparticles for use in hyperglycemic conditions
JP2006083104A (ja) ＩｇＡ腎症予防食品添加剤
CN121197225B (zh) 内脏臭气杆菌在制备治疗高脂血症牙周炎产品中的应用
KR20200144896A (ko) 금어초 추출물을 유효성분으로 함유하는 혈당 강하용 건강기능식품 조성물
CN120585076B (zh) 一种用于癌症患者营养支持的人参皂苷-蛋白肽复合物及其制备方法和应用
US20250017974A1 (en) Fecal transplants for reversing motor and gut symptoms in neurodevelopmental disorders

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination